Study of SKB103 in HER2-negative Breast Cancer
Clinical trial NCT07774624 · NOT_YET_RECRUITING
Trial details
- NCT number
- NCT07774624
- Sponsor
- Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd.
- Status
- NOT_YET_RECRUITING
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2026-08-31
- Primary completion
- 2029-12-31
- Enrollment
- 140
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.